Risk of Intra-Amniotic Infection After Cervical Ripening Balloon for Prelabor Rupture of Membranes: A Systematic Review and Meta-analysis.

Authors

Kamran Hessami, Sarah Tounsi, Manisha Gandhi, Mark A Turrentine

Published in

Obstetrics and gynecology. Jul 09, 2026. Epub Jul 09, 2026.

Abstract

To estimate the odds of intra-amniotic infection among individuals with prelabor rupture of membranes (PROM) who underwent labor induction with a cervical ripening balloon, compared with the odds of infection from a pharmacologic method, by performing a systematic review and meta-analysis.
MEDLINE through the PubMed interface, EMBASE, Web of Science, Cochrane Library, and ClinicalTrials.gov were searched for studies that evaluated intra-amniotic infection among individuals with PROM who were induced with a cervical ripening balloon compared with induction with oxytocin, prostaglandin, or some combination thereof.
Two reviewers independently screened studies, extracted data, and assessed study quality. Odds ratios (OR) with 95% CIs were pooled using a randoms effect model.
Fourteen studies, eight randomized controlled trials (RCTs), and six retrospective cohort studies, which included 2,165 participants, met inclusion criteria; 1,074 participants underwent the cervical ripening balloon and 1,091 received pharmacologic agents. Studies included deliveries that occurred in 2002 through 2023. Six studies were from the United States, three from France, two from Finland, and one each from Iran, the Netherlands, and Sweden. The pooled weighted rate of intra-amniotic infection was 9.4% (95% CI, 5.9-13.6%) with cervical ripening balloon and 7.0% (95% CI, 4.4-10.2%) with pharmacologic methods (OR 1.46; 95% CI, 0.90-2.37; I2 45%). In analyses restricted to RCTs, cervical ripening balloon was associated with increased intra-amniotic infection (OR 1.84; 95% CI, 1.03-3.28; I2 0%), whereas no association was observed in cohort studies (OR 1.25; 95% CI, 0.50-3.13; I2 68%). Rates of intra-amniotic infection were similar between cervical ripening balloon and prostaglandin (OR 1.27; 95% CI, 0.60-2.70; I2 54%) and were similar between cervical ripening balloon and oxytocin (OR 1.66; 95% CI, 0.74-3.75; I2 22%). Among studies assessed as a low risk of bias, cervical ripening balloon was associated with higher odds of intra-amniotic infection than pharmacologic methods (OR 1.74; 95% CI, 1.01-3.01; I2 30%).
Overall intra-amniotic infection odds were similar between cervical ripening balloon and a pharmacologic induction among individuals with PROM. However, analysis limited to RCTs and low risk of bias studies suggests an association between cervical ripening balloon use and increased intra-amniotic infection.
PROSPERO, CRD420251085355.

PMID:
42424638
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.